Troy Rudd, Director, CEO, on May 14, 2026, executed a purchase for 4,225 shares in Aecom (ACM) for $300,060. Following the Form 4 filing with the SEC, Rudd has control over a total of 403,439 common shares of the company, with 142,207 shares held directly and 261,232 controlled indirectly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/868857/000165381126000002/xslF345X05/wk-form4_1778788962.xml
Michael Pokorny, Vice President, Chief Accounting Officer, on May 12, 2026, sold 2,446 shares in Sandisk (SNDK) for $3,488,436. Following the Form 4 filing with the SEC, Pokorny has control over a total of 22,375 common shares of the company, with 22,375 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/2023554/000136324926000032/xslF345X05/edgardoc.xml
John Bicket, 10% Owner, Director, Executive Vice President, Chief Technology Officer, on May 12, 2026, sold 263,900 shares in Samsara (IOT) for $7,436,747. Following the Form 4 filing with the SEC, Bicket has control over a total of 619,711 Class A common shares of the company, with 552,111 shares held directly and 67,600 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1642896/000189510626000010/xslF345X05/form4-05142026_090523.xml
John T. Treace, 10% Owner, Director, Chief Executive Officer, on May 12, 2026, executed a purchase for 153,763 shares in Treace Medical Concepts (TMCI) for $375,505. Following the Form 4 filing with the SEC, Treace has control over a total of 12,482,442 common shares of the company, with 7,158,313 shares held directly and 5,324,129 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1630627/000119312526224391/xslF345X05/ownership.xml